Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
3.49
- 0.05 (-1.41%)
4:00 PM ET on May 27, 2016
Delayed at least 20 minutes.
Day High 3.61
Day Low 3.46
52-Week High 11.65
Volume 371,580
Print Friendly